Tecan Group AG
(OTC: TCGGY)
|
1:30 PM UTC, 03/13/24 | |||
---|---|---|---|---|
Last: $83.50 | Change: +3.46 | %Change: +4.32% | Volume: 1,600 |
Open: | $ 83.50 | Volume: | 1,600 | |
---|---|---|---|---|
High: | $ 83.50 | Yield(%) | 0.70 | |
Low: | $ 83.50 | P/E Ratio (ttm): | 29.36 | |
Dividend ($): | 0.48 | Market Cap ($): | 4.33B | |
EPS ($) | 0.57 | Shares Out: | 64.11M |
% Price Change (last 4 weeks): | -5.81 |
---|---|
% Price Change (last 13 weeks): | -16.70 |
% Price Change (last 26 weeks): | -16.50 |
% Price Change (last 52 weeks): | -10.40 |
% Price Change (year to date): | -17.18 |
Return on Equity (%): | 9.57 |
---|---|
Return on Assets (%): | 6.06 |
Return on Invested Capital (%): | 10.13 |
Gross Profit Margin (%): | 33.40 |
---|---|
Net Profit Margin (%): | 12.29 |
Operating Profit Margin (%): | 12.18 |
50-day Moving Average: | $33.00 |
---|---|
200-day Moving Average: | $n/a |
Avg. Daily Vol. (last 50 days): | 424 |
Avg. Daily Vol. (last 200 days): | n/a |
52-wk high: | $83.50 |
52-wk low: | $56.92 |
Bid: | $n/a |
Ask: | $n/a |
Tecan Group AG operates as a holding company. The firm engages in the development, production and distribution of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. It operates through the following segments: Life Sciences Business and Partnering Business. The Life Sciences Business segment supplies end users with automated workflow solutions, which includes laboratory instruments, software packages, application know-how, services, consumables and spare parts. The Partnering Business segment develops and manufactures original equipment manufacturer instruments and components. The company was founded on March 18, 1980 and is headquartered in Mannedorf, Switzerland.
|
Tecan Group AG
Seestrasse 103 Maennedorf ZH 8708 Phone: 41.44.922.81.11 Fax: 41.44.922.81.12 http://www.tecan.com |
Earnings (1year) ($): | 2.31 |
---|---|
Annual Dividend ($): | 0.48 |
Current P/E Ratio (ttm): | 29.36 |
Book Value ($): | 25.08 |
Cash Flow ($): | 3.53 |
Price/Earnings (x): | 29.36 |
---|---|
Price/Sales (x): | 4.38 |
Price/Book (x): | 3.25 |
Price/Cash Flow (x): | 28.67 |
Quick Ratio (x): | 2.01 |
---|---|
Current Ratio (x): | 2.86 |
LT Debt/Equity (x): | 22.53 |
Total Debt/Equity (x): | 23.48 |